AAAAAA

   
Results: 1-8 |
Results: 8
A phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers
Authors: Evans, TG Bonnez, W Rose, RC Koenig, S Demeter, L Suzich, JA O'Brien, D Campbell, M White, WI Balsley, J Reichman, RC
Citation: Tg. Evans et al., A phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers, J INFEC DIS, 183(10), 2001, pp. 1485-1493
Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies
Authors: Morse, GD Reichman, RC Fischl, MA Para, M Leedom, J Powderly, W Demeter, LM Resnick, L Bassiakos, Y Timpone, J Cox, S Batts, D
Citation: Gd. Morse et al., Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies, ANTIVIR RES, 45(1), 2000, pp. 47-58
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)
Authors: Demeter, LM Shafer, RW Meehan, PM Holden-Wiltse, J Fischl, MA Freimuth, WW Para, MF Reichman, RC
Citation: Lm. Demeter et al., Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260), ANTIM AG CH, 44(3), 2000, pp. 794-797
Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture
Authors: Archer, RH Dykes, C Gerondelis, P Lloyd, A Fay, P Reichman, RC Bambara, RA Demeter, LM
Citation: Rh. Archer et al., Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture, J VIROLOGY, 74(18), 2000, pp. 8390-8401
Analysis of env sequence evolution in human immunodeficiency virus-infected patients receiving therapy with nonnucleoside reverse-transcriptase inhibitors
Authors: Dykes, C Meotsikapun, P Dexter, A Berrios, L Chiulli, M Reichman, RC Demeter, LM
Citation: C. Dykes et al., Analysis of env sequence evolution in human immunodeficiency virus-infected patients receiving therapy with nonnucleoside reverse-transcriptase inhibitors, J INFEC DIS, 182(1), 2000, pp. 316-320
Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial
Authors: Benson, CA Williams, PL Cohn, DL Becker, S Hojczyk, P Nevin, T Korvick, JA Heifets, L Child, CC Lederman, MM Reichman, RC Powderly, WG Notario, GF Wynne, BA Hafner, R
Citation: Ca. Benson et al., Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial, J INFEC DIS, 181(4), 2000, pp. 1289-1297
The P236L delavirdine-resistant human immunodeficiency virus type 1 mutantis replication defective and demonstrates alterations in both RNA 5 '-end-and DNA 3 '-end-directed RNase H activities
Authors: Gerondelis, P Archer, RH Palaniappan, C Reichman, RC Fay, PJ Bambara, RA Demeter, LM
Citation: P. Gerondelis et al., The P236L delavirdine-resistant human immunodeficiency virus type 1 mutantis replication defective and demonstrates alterations in both RNA 5 '-end-and DNA 3 '-end-directed RNase H activities, J VIROLOGY, 73(7), 1999, pp. 5803-5813
Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection
Authors: Luque, AE Demeter, LM Reichman, RC
Citation: Ae. Luque et al., Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection, J INFEC DIS, 179(6), 1999, pp. 1405-1409
Risultati: 1-8 |